Dual-action mRNA vaccine takes aim at aggressive skin cancer

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Super Micro Computer Q1 earnings preview: What to expect

Super Micro Computer (SMCI) is set to announce its first quarter earnings on Tuesday, November 4th, after the market close.

CREATE Medicines to Present Late-Breaking Clinical Data on MT-302 at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting

CREATE Medicines, Inc. (formerly Myeloid Therapeutics), a clinical-stage biotech pioneering in vivo multi-immune programming, today announced that clinical results from its Phase 1 MYE Symphony trial ...

Moderna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma

Moderna, Inc. (NASDAQ:MRNA) today announced that the first patient has been dosed in a Phase 1/2 study of mRNA-2808, the ...
Bizcommunity

Aspen Pharmacare reaches €25m settlement in mRNA contract dispute

Aspen Pharmacare said it had reached a €25m settlement in a contractual dispute with a client over a manufacturing and ...